273 related articles for article (PubMed ID: 27473350)
1. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
Maas KH; Chuan S; Harrison E; Cook-Andersen H; Duleba AJ; Chang RJ
Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
[TBL] [Abstract][Full Text] [Related]
3. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
4. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
5. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
Maas KH; Chuan SS; Cook-Andersen H; Su HI; Duleba A; Chang RJ
J Clin Endocrinol Metab; 2015 Jan; 100(1):293-300. PubMed ID: 25313914
[TBL] [Abstract][Full Text] [Related]
6. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Moran C; Reyna R; Boots LS; Azziz R
Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
[TBL] [Abstract][Full Text] [Related]
8. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
10. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
Sahin Y; Keleştimur F
Hum Reprod; 1997 May; 12(5):910-3. PubMed ID: 9194638
[TBL] [Abstract][Full Text] [Related]
11. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
12. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
[TBL] [Abstract][Full Text] [Related]
13. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
Farah-Eways L; Reyna R; Knochenhauer ES; Bartolucci AA; Azziz R
Fertil Steril; 2004 Jan; 81(1):120-5. PubMed ID: 14711554
[TBL] [Abstract][Full Text] [Related]
14. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
15. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
[TBL] [Abstract][Full Text] [Related]
16. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
[TBL] [Abstract][Full Text] [Related]
17. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
[TBL] [Abstract][Full Text] [Related]
18. 17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome.
Hou J; Cook-Andersen H; Su HI; Shayya R; Maas KH; Burt-Solorzano CM; Kumar A; Chang RJ
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):835-40. PubMed ID: 27166718
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.
McCartney CR; Bellows AB; Gingrich MB; Hu Y; Evans WS; Marshall JC; Veldhuis JD
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E902-8. PubMed ID: 14736706
[TBL] [Abstract][Full Text] [Related]
20. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.
Wu XK; Zhou SY; Sallinen K; Pöllänen P; Erkkola R
Eur J Endocrinol; 2000 Sep; 143(3):383-8. PubMed ID: 11022181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
